English EN Spanish ES French FR Chinese (Simplified) ZH-CN
Print Friendly, PDF & Email

NCT/Study#

NCT03564691 /

MK-4830-001

A Phase 1 Open Label, Multi-Arm, Multicenter Study Of MK-4830 As Monotherapy And In Combination With Pembrolizumab For Participants With Advanced Solid Tumors

DISEASE GROUP:
Phase 1 Clinical Trials
current phase:
Phase I
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: